Insider · CIK 0001317296

Peabody Robert

Reports to the SEC for 3 companies · ALAMEDA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001317296

Forms 4 and 5

Insider transactions

15 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2016-02-28	Asterias Biotherapeutics, Inc.Stock Options (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2015-07-10	LCTXLineage Cell Therapeutics, Inc. · Option to Purchase Common SharesA Award	Sr. VP and CFO	AAward	+100K sh	—	—	100,000
2015-02-13	Asterias Biotherapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2015-02-13	Asterias Biotherapeutics, Inc.Restricted Stock UnitsA Award	Director	AAward	+3,846 sh	—	—	3,846
2014-08-15	Asterias Biotherapeutics, Inc.J Other	Director	JOther	+41 sh	—	—	41
2014-07-22	LCTXLineage Cell Therapeutics, Inc.S Sale	Sr. VP and CFO	SSale	−100K sh	$2.65	−$265K	315,777
2014-07-21	LCTXLineage Cell Therapeutics, Inc.M Exercise/Conversion	Sr. VP and CFO	MExercise/Conversion	+475K sh	$0.50	+$238K	505,400
2014-07-21	LCTXLineage Cell Therapeutics, Inc.F Tax Payment	Sr. VP and CFO	FTax Payment	−89.6K sh	$2.65	−$238K	415,777
2014-07-21	LCTXLineage Cell Therapeutics, Inc. · Option to Purchase Common SharesM Exercise/Conversion	Sr. VP and CFO	MExercise/Conversion	−475K sh	—	—	0
2014-03-20	LCTXLineage Cell Therapeutics, Inc. · Option to Purchase Common SharesJ Other	Sr. VP and CFO	JOther	+100K sh	—	—	100,000
2014-01-06	LCTXLineage Cell Therapeutics, Inc.M Exercise/Conversion	Sr. VP and CFO	MExercise/Conversion	+25K sh	$0.50	+$12.5K	30,400
2014-01-06	LCTXLineage Cell Therapeutics, Inc. · Option to Purchase Common SharesM Exercise/Conversion	Sr. VP and CFO	MExercise/Conversion	−25K sh	—	—	475,000
2013-02-20	LCTXLineage Cell Therapeutics, Inc. · Option to Purchase Common SharesJ Other	Sr. VP and CFO	JOther	+100K sh	—	—	100,000
2011-06-22	LCTXLineage Cell Therapeutics, Inc.P Purchase	Sr. VP and CFO	PPurchase	+5,400 sh	$4.45	+$24K	5,400
2005-07-06	Ocata Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director, VP - Grant Administration	AAward	+400K sh	$0.85	+$340K	400,000

Recent filings

Accepted (ET)
Mar 14
Asterias Biotherapeutics, Inc.0001140361-16-055906
SEC(opens sec.gov)
Jul 144
BIOTIME INC0001209191-15-060848
SEC(opens sec.gov)
Feb 184
Asterias Biotherapeutics, Inc.0001209191-15-015731
SEC(opens sec.gov)
Aug 194
Asterias Biotherapeutics, Inc.0001209191-14-053591
SEC(opens sec.gov)
Jul 234
BIOTIME INC0001209191-14-048769
SEC(opens sec.gov)
Mar 244
BIOTIME INC0001209191-14-022856
SEC(opens sec.gov)
Jan 84
BIOTIME INC0001209191-14-002461
SEC(opens sec.gov)
Feb 224
Peabody Robert0001209191-13-011085
SEC(opens sec.gov)
Jun 234
Peabody Robert0001209191-11-036001
SEC(opens sec.gov)
Jul 84
ADVANCED CELL TECHNOLOGY, INC.0001179110-05-013993
SEC(opens sec.gov)

Companies

Address

1301 HARBOR BAY PARKWAY

ALAMEDA, CA, 94502